MRSIX | VTISX | MRSIX / VTISX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 8 years | - |
Gain YTD | 5.762 | 6.094 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16B | 443B | 4% |
Annual Yield % from dividends | 1.60 | 3.32 | 48% |
Returns for 1 year | 8.04 | 8.85 | 91% |
Returns for 3 years | 0.21 | 1.14 | 18% |
Returns for 5 years | 24.71 | 14.05 | 176% |
Returns for 10 years | 62.12 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 62.33 | 0.78 | +1.27% |
Virtus LifeSci Biotech Products ETF | |||
NJUL | 63.82 | -0.12 | -0.19% |
Innovator Nasdaq-100 Power Bfr ETF Jul | |||
TBF | 24.01 | -0.06 | -0.25% |
ProShares Short 20+ Year Treasury | |||
TCHP | 43.68 | -0.13 | -0.30% |
T. Rowe Price Blue Chip Growth ETF | |||
OEF | 296.56 | -1.54 | -0.52% |
iShares S&P 100 ETF |